Search clinical trials for: SENTI-202

Total 1168 results

Bausch Health Americas, Inc.

Terminated

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Hepatitis B, Chronic
Novindiet Clinic
Tehran University of Medical Sciences; University of Nottingham

Completed

Effects of Late Dinner Against Early Dinner on Weight Loss Healthy Obese Women

Obesity | Overweight

Iran, Islamic Republic of
Repros Therapeutics Inc.

Completed

Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis

Endometriosis

United States
Alkermes, Inc.

Completed

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion

Symptomatic Focal Vitreomacular Adhesion

United States
Nicolas DEMARTINES

Terminated

Stomaplasty Ring (KoringTM) for Prevention of Parastomal Hernia (StoKo)

Parastomal Hernia

Switzerland
University of Turin, Italy

Completed

Occurrence of Ventilator Associated Pneumonia in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion Drainage (VICTOR)

Respiratory Failure

Italy
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea

Uncomplicated Urogenital Gonorrhea

United States
vTv Therapeutics

Completed

Add Glucokinase Activator to Target A1c (AGATA)

Diabetes Mellitus, Type 2

United States
University Hospital, Caen

Unknown

Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke (ROTEMPredict)

Stroke

France
Stealth BioTherapeutics Inc.

Withdrawn

A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure

Heart Failure

Bulgaria
National OncoVenture
Hanmi Pharmaceutical Company Limited

Completed

NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors (NSCLC)

Increased Drug Resistance

Korea, Republic of
Bristol-Myers Squibb

Completed

Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

Melanoma

Japan
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults

Constipation

United States
YM BioSciences

Completed

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

Metastatic/Recurrent Breast Cancer

Russian Federation, Georgia, Ukraine
Ardea Biosciences, Inc.

Completed

Gout Dose Response Study

Hyperuricemia

Poland, United States, Canada, Bulgaria, Germany, Georgia, Czech Republic
Innate Pharma

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse

United States
Biogen

Terminated

Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors

Tumors

United States
Vital Therapies, Inc.

Completed

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

Fulminant Hepatic Failure

United States
Vital Therapies, Inc.

Withdrawn

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF) (ELAD)

Fulminant Hepatic Failure

United States
ZARS Pharma Inc.

Completed

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Pain

United States
Pfizer

Terminated

Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

Diabetes Complications | Foot Ulcer, Diabetic

United States
BioCryst Pharmaceuticals

Completed

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

Gout

United States
Sequel Pharmaceuticals, Inc

Terminated

Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation (TUNDRA-AF)

Atrial Fibrillation

Denmark, Israel
National Institute of Allergy and Infectious Diseases...

Completed

Tuberculosis Immunity in Children

Tuberculosis

United States
CoMentis
Juvenile Diabetes Research Foundation

Completed

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

Osteoarthritis

Poland, Spain, Hong Kong, United States, Canada, Hungary, Netherlands, Brazil, Mexico, Argentina
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease

Arrhythmia

United States, Canada
Daiichi Sankyo, Inc.

Completed

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

Coronary Heart Disease

United States
Sandoz

Completed

A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia

HIV Infections | Cytopenias

United States
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

A Machine Learning Prediction Model for Delayed CIPONV

Postoperative Nausea and Vomiting

China
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

Non-Alcoholic Steatohepatitis (NASH)

China
AceLink Therapeutics, Inc.
Tigermed Consulting Co., Ltd

Recruiting

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Fabry Disease

China
Aadi Bioscience, Inc.

Recruiting

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Neuroendocrine Tumors | Pancreatic Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Tumor | NET | Pulmonary Neuroendocrine Tumor

United States
NiKang Therapeutics, Inc.
Pfizer

Recruiting

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Neoplasms | Kidney Cancer | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Kidney Diseases | Urologic Diseases | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Clear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Recurrent... and other conditions

United States
Akeso

Not yet recruiting

Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients

Colorectal Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

Autoimmune Hepatitis

China
Gannex Pharma Co., Ltd.

Recruiting

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

Non-alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

China
Akeso

Recruiting

A Study of AK112 in Advanced Malignant Tumors

Advanced Malignant Tumors

China
Akeso

Recruiting

A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC

Non-small Cell Lung Cancer

China
Impact Therapeutics, Inc.

Not yet recruiting

Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment

mCRPC

Australia, United States, China
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

HSK7653 in Chinese Patients With Impaired Glucose Tolerance

Impaired Glucose Tolerance

China
Dana-Farber Cancer Institute
Bayer; Decipher Biosciences

Recruiting

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Prostate Cancer

United States
Viking Therapeutics, Inc.

Completed

A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE)

NASH - Nonalcoholic Steatohepatitis

United States, Belgium, France, Mexico, Puerto Rico
Reneo Pharma Ltd

Terminated

An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead)

Primary Mitochondrial Myopathy

Spain, Australia, Belgium, Denmark, Canada, United Kingdom, France, Germany, Hungary, Italy, Netherlands, New Zealand
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Completed

KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer

Gastric/Gastroesophageal Junction Cancer

China
Alterity Therapeutics

Enrolling by invitation

Biomarker Study of ATH434 in Participants With MSA

Multiple System Atrophy

United States
Intercept Pharmaceuticals

Terminated

Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

Liver Cirrhosis, Biliary

United States, Spain, Canada, United Kingdom, France, Germany, Austria, Netherlands
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) (STRONG SCD)

Sickle Cell Disease

United States, United Kingdom, Lebanon
Northwestern University
NorthShore University HealthSystem

Completed

Mind-Body Health in Uro-Oncology: Research Study

Kidney Cancer | Prostate Cancer | Bladder Cancer

United States

Search clinical trials for: SENTI-202

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations